Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection.
about
Evidence that the effector mechanism of skin allograft rejection is antigen-specific.T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis.Phenotypic and functional characterization of lymphocytes that bind human microvascular endothelial cells in vitro. Evidence for preferential binding of natural killer cells.Mononuclear cell pulmonary vasculitis in NZB/W mice. II. Immunohistochemical characterization of the infiltrating cellsCell surface phenotypes of radiolabeled immune long-lived lymphocytes that selectively localize in syngeneic tumours.Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigensSkin graft rejection by beta 2-microglobulin-deficient mice.Malignant growth in the normal host after variant selection in vitro with cytolytic T-cell linesRejection of stable cultured allografts by active or passive (adoptive) immunization.Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. I. Alloreactive suppressor cells rather than killer T cells appear to be the decisive effector cells in lethal graft-vs.-host diseaseRegression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer.Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells.Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejectionTherapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cellsPhenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection.Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats.Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.Mononuclear phagocytes: a major population of effector cells responsible for rejection of allografted tumor cells in mice.Acquired immunological tolerance of foreign cells is impaired by recombinant interleukin 2 or vitamin A acetate.Renal transplant immunology in the last 20 years: A revolution towards graft and patient survival improvement.Functions of purified L3T4+ and Lyt-2+ cells in vitro and in vivo.The in vitro generation and functional analysis of murine T cell populations and clones specific for a protozoan parasite, Leishmania tropica.Functions of rat T-lymphocyte subsets isolated by means of monoclonal antibodies.Mechanisms of allograft rejection: the roles of cytotoxic T-cells and delayed-type hypersensitivity.Cellular basis of allograft rejection.Cellular and molecular mechanisms underlying IL-12-induced tumor regression.Immunohistological observations in rat kidney allografts after local steroid administrationHaptens can serve as surrogate transplantation antigens in a manner that demonstrates H-2 restriction of graft rejection.Mechanisms for recognition of tumor antigens and mediation of anti-tumor effect by noncytolytic Lyt-2+ T cell subset.A controlled serial ultrastructural tracer study of first-set cardiac allograft rejection in the rat. Evidence that the microvascular endothelium is the primary target of graft destruction.A reexamination of the role of LYT-2-positive T cells in murine skin graft rejection.Cloned LYT-2+ cytolytic T lymphocytes destroy allogeneic tissue in vivo.Cellular requirements for renal allograft rejection in the athymic nude rat.Immunoregulation of murine plasmacytoma. I. Generation of anomalous killer cells in vitro by cocultivation with MOPC 104E.Fatal meningitis following lymphocytic choriomeningitis virus infection reflects delayed-type hypersensitivity rather than cytotoxicity.Mediation of in vivo tumor-neutralizing activity by Lyt-2+ as well as L3T4+ T cell subsets.Cytotoxic activity of CD4+ T cells against autologous tumor cells.
P2860
Q33656752-B26EBC26-0F4F-40ED-BA95-9B361CAB92AFQ34540653-97754D29-6612-46C5-9269-DD9D28F38C3FQ34575567-99162F80-3E8F-4D49-8633-89AA837910EEQ35836178-C52FD9B7-E6EF-442F-938B-E61C2F377A18Q35884998-393F8694-34CA-46AB-8AEC-EF446139D774Q36230333-E0FAB755-E9AD-4467-8F42-92704E6E47B0Q36231155-8907F866-3058-4F80-8BC9-1CAD05428564Q36267070-66DCBC73-049D-4E71-B892-2E590262C210Q36285638-668DB961-9E10-484D-A096-2671E159C3E5Q36346431-BCF1C941-411C-4F85-A2BB-49DA0B85E1D2Q36346766-2C8051BA-B54B-48F7-B82D-3475F2E08DBEQ36347151-9D523CE6-8927-4913-B84A-70E3F13723CEQ36347791-E4E473B2-60C2-4D68-87D2-AED38EDA222EQ36349864-41395FBE-904E-457E-8237-EDE8EDB6FDFBQ36350025-9CAF7220-B343-440A-955B-92AA0AAB8657Q36351226-0B59B5E8-AB59-4907-894C-D4F9280C357FQ36352580-A4FA6B22-0C90-4CE9-810F-BF4C6016A897Q36353313-A0F7E966-B410-43A9-B1B5-EC0E05E3C1C3Q36355820-AC2C6F4E-FE2D-4D77-91F1-6EFA3121F94BQ37408690-0CE79629-C459-4C61-A9B4-5CFA43F397AFQ37675531-25FE9F46-5FB4-4892-B12D-A4DC4FFD0193Q38967258-4D765477-69AC-414D-8CC9-C709EB66BB7AQ39479246-E627EAE5-DB5F-4139-9B26-665D40444038Q40102610-7E3D7F3B-9B1A-4FCF-A88A-551B54582D41Q40115728-FC09B8CB-1800-4477-B703-5FAA9AF139A3Q40175023-44401A44-9C62-4728-B856-1EB9F07A9002Q40175030-30698635-5390-4969-97A9-08BA9725BC87Q41261303-881BC4A3-D420-470A-8DEF-5BB4696579E5Q41828235-CC68772E-0F39-493B-BFB3-64BC9E893A46Q41833022-39A1718B-A925-401D-9E08-AD094787558AQ41912662-2F1546A8-E192-4DF9-BCA5-1D99A9C51140Q42124002-B3B5766F-B3A4-4D69-BF1B-B5C804F903DFQ42936774-E5EB218B-0CE2-44F2-96B7-95403912156AQ42936777-612D6576-677D-4CBE-8F53-6E51352C3973Q42939643-1F6451A9-46A2-4751-B13C-2BC7BDBD60E4Q43561202-F1BB6266-A491-4B7B-8E9E-5DAF8EF0EE72Q45795247-E56D22AB-8F79-45CC-BEC7-AE8883623A08Q54992787-5DCCD890-730C-4DB1-8C50-6F798465D31DQ55024632-C753B763-B219-4D7C-9F5D-9CBD6DB027FF
P2860
Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh
1981年學術文章
@zh-hant
name
Cells mediating graft rejectio ...... mediate skin graft rejection.
@ast
Cells mediating graft rejectio ...... mediate skin graft rejection.
@en
type
label
Cells mediating graft rejectio ...... mediate skin graft rejection.
@ast
Cells mediating graft rejectio ...... mediate skin graft rejection.
@en
prefLabel
Cells mediating graft rejectio ...... mediate skin graft rejection.
@ast
Cells mediating graft rejectio ...... mediate skin graft rejection.
@en
P2093
P2860
P356
P1476
Cells mediating graft rejectio ...... mediate skin graft rejection.
@en
P2093
B E Loveland
I F McKenzie
P M Hogarth
P2860
P304
P356
10.1084/JEM.153.5.1044
P407
P577
1981-05-01T00:00:00Z